Recent Patents on Anti-Cancer Drug Discovery 2009-01-01

The anti-cancer activity of noscapine: a review.

Massoud Mahmoudian, Parvaneh Rahimi-Moghaddam

Index: Recent Pat. Anticancer. Drug Discov. 4(1) , 92-7, (2009)

Full Text: HTML

Abstract

Noscapine is an isoqiunoline alkaloid found in opium latex. Unlike most other alkaloids obtained from opium latex, noscapine is not sedative and has been used as antitussive drug in various countries. Recently, it has been introduced as an anti-mitotic agent. This drug can be used orally. When the resistance to other anti-cancer drugs such as paclitaxel manifests, noscapine might be effective. Therefore, noscapine and its analogs have great potential as novel anti-cancer agents.

Related Compounds

  • Noscapine

Related Articles:

Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

2014-08-01

[Am. J. Public Health 104(8) , e32-42, (2014)]

Adlumiceine methyl ester, a new alkaloid from Fumaria vaillantii.

2014-12-01

[J. Asian Nat. Prod. Res. 16(12) , 1148-52, (2014)]

Peloruside, laulimalide, and noscapine interactions with beta-tubulin.

2012-11-01

[Pharm. Res. 29(11) , 2985-93, (2012)]

Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent, noscapine in cancer cells.

2012-12-01

[Curr. Drug Metab. 13(10) , 1476-83, (2012)]

A review on noscapine, and its impact on heme metabolism.

2013-03-01

[Curr. Drug Metab. 14(3) , 351-60, (2013)]

More Articles...